Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for April 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.Rare Variants …

I had a friend of mine send me some guidelines on the use of low carb, high protein programs for diabetes management. One of the tenets of these guidelines was the value of replacing animal protein with vegetable proteins.  Seems to make sense when you think about saturated fat, and …

Increased cardiovascular risk found in women with glucose concentrations at the upper end of the normal range during pregnancy.

To date, there is limited evidence concerning the potential health benefits of eating nuts for persons with T2D.

Could the most inexpensive treatment for arterial stiffness be a healthy walk?

In this Exclusive Interview, Lora K. Heisler talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about harnessing serotonin in the treatment of obesity and type 2 diabetes.

In this Exclusive Interview transcript, Lora K. Heisler talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about using serotonin in the treatment of obesity and type 2 diabetes.

Variants are associated with reproductive and metabolic traits in PCOS families

Trial shows superiority of liraglutide with respect to glycemic control in children, adolescents

Ratio of prematurity, small for gestational age higher in newborns with disorders of sex development